Bio-Rad Laboratories Class B
BIO.B
8 hedge funds and large institutions have $6.14M invested in Bio-Rad Laboratories Class B in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.12% less ownership
Funds ownership: 0.64% → 0.52% (-0.12%)
40% less capital invested
Capital invested by funds: $10.2M → $6.14M (-$4.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Copperwynd Financial
Scottsdale,
Arizona
|
+$543K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$14.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$776 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.02M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$486K |
| 3 |
Morgan Stanley
New York
|
-$64.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $5.13M | – | – | – |
|
|
CF
2
Copperwynd Financial
Scottsdale,
Arizona
| $483K | +$543K | +2,100 | New |
|
3
Renaissance Technologies
New York
| $253K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $132K | +$776 | +3 | +0.5% |
|
|
5
Morgan Stanley
New York
| $127K | -$64.7K | -250 | -31% |
|
|
6
Wells Fargo
San Francisco,
California
| $13K | +$14.5K | +56 | New |
|
7
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
8
Dimensional Fund Advisors
Austin,
Texas
| – | -$2.02M | -6,429 | Closed |
|
|
9
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$486K | -1,555 | Closed |
|
BIO.B Hedge Fund Activity: Q4 2018 in Review
8 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q4 2018, worth a combined $6.14M — down 40% from $10.2M a quarter earlier.
Fund positioning in BIO.B was balanced in Q4 2018: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Copperwynd Financial, opening a new position worth an estimated $543K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $2.02M sold.
- 8 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $6.14M of Bio-Rad Laboratories Class B stock for Q4 2018, down 40% quarter-over-quarter.
- 2 funds opened new Bio-Rad Laboratories Class B positions in Q4 2018 and 2 closed out, a net change of 0 holders.
- The largest Bio-Rad Laboratories Class B buyer in Q4 2018 was Copperwynd Financial, an estimated $543K added.
- The largest Bio-Rad Laboratories Class B seller in Q4 2018 was Dimensional Fund Advisors, an estimated $2.02M sold.
Based on aggregated 13F filings for Q4 2018.